What is Horizon’s generic fidaxomicin date?
The provided information doesn’t include any details about a specific “Horizon” generic fidaxomicin timeline (for example, an ANDA filing date, approval date, or market launch date). To give the correct “date,” I need the exact product identifier or jurisdiction.
If you meant the US, tell me whether you’re looking for:
- FDA approval date for the generic,
- the “first commercial marketing” date (launch),
- the date a patent/exclusivity barrier ends, or
- a court/litigation “stay” end date affecting launch.
Which “fidaxomicin generic” and which Horizon are you referring to?
Several versions of “fidaxomicin” could be referenced (different strengths, dosage forms, or brand vs generic). Also, companies with “Horizon” in the name can differ by country.
Share any of the following and the date can be pinned down precisely:
- brand name you mean (fidaxomicin brand name is Dificid in the US),
- strength/dosage form (e.g., 200 mg tablets),
- country (US/Canada/EU/UK, etc.),
- the Horizon company full name, or
- an FDA product page link / NDA/ANDA number.
If you mean US FDA launch timing: what dates usually control the generic?
For US generic medicines, the key dates often come from:
- FDA approval/“tentative approval” for the ANDA,
- patent protections listed in the Orange Book,
- exclusivity periods (if any), and
- any litigation-related FDA stays that delay launch even after approval.
Without the specific “Horizon” product and the relevant patent/exclusivity record, the exact “generic fidaxomicin date” can’t be determined from the info here.
Send one detail and I’ll return the exact date
Reply with either:
1) the ANDA number (or FDA link) for Horizon’s fidaxomicin generic, or
2) the exact Horizon company name + country, or
3) whether you want “FDA approval date” or “launch date,”
and I’ll give the specific date you’re asking for.